Anja Vogt

2.6k total citations
66 papers, 1.5k citations indexed

About

Anja Vogt is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Economics and Econometrics. According to data from OpenAlex, Anja Vogt has authored 66 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Surgery, 21 papers in Cardiology and Cardiovascular Medicine and 18 papers in Economics and Econometrics. Recurrent topics in Anja Vogt's work include Lipoproteins and Cardiovascular Health (49 papers), Antiplatelet Therapy and Cardiovascular Diseases (13 papers) and Pharmaceutical Economics and Policy (11 papers). Anja Vogt is often cited by papers focused on Lipoproteins and Cardiovascular Health (49 papers), Antiplatelet Therapy and Cardiovascular Diseases (13 papers) and Pharmaceutical Economics and Policy (11 papers). Anja Vogt collaborates with scholars based in Germany, United States and United Kingdom. Anja Vogt's co-authors include Elisabeth Steinhagen‐Thiessen, Klaus G. Parhofer, Ursula Kassner, Wolfgang Ramlow, E. Roeseler, Franz Heigl, Bernd Eber, Robert Weiss, Christie M. Ballantyne and Emma Duffield and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Anja Vogt

59 papers receiving 1.4k citations

Peers

Countries citing papers authored by Anja Vogt

Since Specialization

Citations

This map shows the geographic impact of Anja Vogt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anja Vogt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anja Vogt more than expected).

Fields of papers citing papers by Anja Vogt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anja Vogt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anja Vogt. The network helps show where Anja Vogt may publish in the future.

Co-authorship network of co-authors of Anja Vogt

This figure shows the co-authorship network connecting the top 25 collaborators of Anja Vogt. A scholar is included among the top collaborators of Anja Vogt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anja Vogt. Anja Vogt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evinacumab in homozygous familial hypercholesterolemia caused by LDLRAP 1 – first data of 2 unrelated cases 2024 ·Atherosclerosis ·Anja Vogt	0
2	Statinunverträglichkeit – Statinverträglichkeit 2023 ·Die Innere Medizin ·Anja Vogt	0
3	Lipidsenkung 2023 ·Benjamin Lechner, Anja Vogt	0
4	Hypercholesterinämie - Wie erreiche ich ein LDL < 55 mg/dl? 2020 ·MMW - Fortschritte der Medizin ·Anja Vogt	1
5	Lipoprotein(a)—antisense therapy 2019 ·PubMed ·Anja Vogt	9
6	Treatment-related and health-related quality of life in lipoprotein apheresis patients 2018 ·Journal of clinical lipidology ·Véronique De Gucht, Krister Cromm, Anja Vogt, Ulrich Julius, Bernd Hohenstein, (unknown), Wolfgang Ramlow, Volker Schettler, Stan Maes	9
7	Current insights into the German Lipoprotein Apheresis Registry (GLAR) – Almost 5 years on 2017 ·Atherosclerosis Supplements ·Volker Schettler, C. Neumann, Christian Peter, Thomas Zimmermann, Ulrich Julius, E. Roeseler, Franz Heigl, P. Grützmacher, Holger Blume, Anja Vogt, B.R. Jaeger, Frank van Buuren, Klaus‐Peter Mellwig, H.-U. Klör	19
8	Alirocumab in patients with heterozygous familial hypercholesterolemia undergoing lipoprotein apheresis: Rationale and design of the ODYSSEY ESCAPE trial 2016 ·Journal of clinical lipidology ·Patrick M. Moriarty, Klaus G. Parhofer, Stephan P. Babirak, Emil M. deGoma, P. Barton Duell, Bernd Hohenstein, Wolfgang Ramlow, Vinaya Simha, Elisabeth Steinhagen‐Thiessen, Paul D. Thompson, Anja Vogt, Berndt von Stritzky, Yunling Du, Garen Manvelian	15
9	Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial 2016 ·European Heart Journal ·Patrick M. Moriarty, Klaus G. Parhofer, Stephan P. Babirak, Marc-Andre Cornier, P. Barton Duell, Bernd Hohenstein, Josef Leebmann, Wolfgang Ramlow, Volker Schettler, Vinaya Simha, Elisabeth Steinhagen‐Thiessen, Paul D. Thompson, Anja Vogt, Berndt von Stritzky, Yunling Du, Garen Manvelian	135
10	Quality of life in patients treated with lipoprotein apheresis 2015 ·Journal of clinical lipidology ·Adrian Rosada, Ursula Kassner, (unknown), Andrew R. Bender, Elisabeth Steinhagen‐Thiessen, Anja Vogt	18
11	The potential of mipomersen, an ApoB synthesis inhibitor, to reduce necessity for LDL-apheresis in patients with heterozygous familial hypercholesterolemia and coronary artery disease 2013 ·Expert Opinion on Pharmacotherapy ·Anja Vogt, Klaus G. Parhofer	16
12	Are the elderly different? 2012 ·Zeitschrift für Gerontologie und Geriatrie ·(unknown), Ursula Müller‐Werdan, (unknown), Anja Vogt, (unknown), Uwe Raaz, (unknown), M. Buerke, Karl Werdan, Axel Schlitt	5
13	Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events 2009 ·Nature Reviews Cardiology ·B.R. Jaeger, (unknown), Dorothea Nagel, Franz Heigl, Anja Vogt, E. Roeseler, Klaus G. Parhofer, Wolfgang Ramlow, Michael Koch, Gerd Utermann, Carlos A. Labarrere, D. Seidel	225
14	Single Lipoprotein Apheresis Session Improves Cardiac Microvascular Function in Patients With Elevated Lipoprotein(a): Detection by Stress/Rest Perfusion Magnetic Resonance Imaging 2009 ·Therapeutic Apheresis and Dialysis ·Steffen Bohl, Ursula Kassner, Rahel Eckardt, Wolfgang Utz, (unknown), Andreas Busjahn, (unknown), Hassan Abdel‐Aty, Reinhard Klingel, Santica M. Marcovina, Rainer Dietz, Elisabeth Steinhagen‐Thiessen, Jeanette Schulz‐Menger, Anja Vogt	28
15	Dyslipidemia in primary care – prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS) 2008 ·Cardiovascular Diabetology ·Elisabeth Steinhagen‐Thiessen, Peter Bramlage, Christian Lösch, Hans Hauner, Heribert Schunkert, Anja Vogt, Jürgen Wasem, Karl‐Heinz Jöckel, Susanne Moebus	45
16	Prolonged-release nicotinic acid for the management of dyslipidemia: an update including results from the NAUTILUS study 2007 ·SHILAP Revista de lepidopterología ·Anja Vogt, Ursula Kassner, Ulrike Gottwald‐Hostalek, Elisabeth Steinhagen‐Thiessen	1
17	Efficacy and Safety of Rosuvastatin 40 mg Alone or in Combination With Ezetimibe in Patients at High Risk of Cardiovascular Disease (Results from the EXPLORER Study) 2007 ·The American Journal of Cardiology ·Christie M. Ballantyne, Robert Weiss, Tiziano Moccetti, Anja Vogt, Bernd Eber, (unknown), Emma Duffield	161
18	Antimicrobial drug use in hospitalised paediatric patients: a cross-national comparison between Germany and Croatia 2005 ·Pharmacoepidemiology and Drug Safety ·Mike Ufer, (unknown), Anja Vogt, Goran Palčevski, Igor Francetić, Stephan C. Reinalter, H. W. Seyberth, Vera Vlahović–Palčevski	18
19	Molecular characterization of familial hypercholesterolemia in German and Greek patients 2004 ·Human Mutation ·George Dedoussis, Janine Genschel, Bettina Bochow, Christos Pitsavos, John Skoumas, (unknown), (unknown), Pavlos Toutouzas, Anja Vogt, Ursula Kassner, (unknown), Hartmut Schmidt	36
20	Autosomal Recessive Hypercholesterolemia in Three Sisters with Phenotypic Homozygous Familial Hypercholesterolemia: Diagnostic and Therapeutic Procedures 2004 ·Therapeutic Apheresis and Dialysis ·(unknown), Anja Vogt, Kenneth R. Wilund, (unknown), Elisabeth Steinhagen‐Thiessen, Ursula Kassner	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact